Showing results (321-330 of 416) with videos related to
Sort By:
Pageof 42
Journal of Women'S Health (2002)|February 28, 2020
Sex-Based Differences in Melanoma Survival in a Contemporary Patient CohortTina J Hieken, Amy E Glasgow, Elizabeth Ann L Enninga, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Inability of bm14 mice to respond to Theiler's murine encephalomyelitis virus is caused by defective antigen presentation, not repertoire selectionMatthew S Block, Yanice V Mendez-Fernandez, Virginia P Van Keulen, et al.Journal of Neurodevelopmental Disorders|October 18, 2019
Vocabulary comprehension in adults with fragile X syndrome (FXS)Anne Hoffmann, Sue Ellen Krause, Joanne Wuu, et al.Gynecologic Oncology|June 11, 2020
Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancerDeepa Maheswari Narasimhulu, Michaela E McGree, Amy L Weaver, et al.Pathogens & Immunity|September 8, 2022
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and InfluenzaEmmanuel Y Merigeon, Dong Yang, Elizabeth A Ihms, et al.Gynecologic Oncology|July 28, 2024
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trialAditi Gupta, Roisin E O'Cearbhaill, Matthew S Block, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 26, 2003
Effect of insulin and growth hormone on plasma leptin in periparturient dairy cowsBrian J Leury, Lance H Baumgard, Stephanie S Block, et al.Oncology|December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patientsAminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 20, 2021
Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodesFrancesco Multinu, Simone Garzon, Amy L Weaver, et al.Gynecologic Oncology|June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomesRiham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.Pageof 42